InvestorsHub Logo
Followers 275
Posts 32760
Boards Moderated 0
Alias Born 11/14/2013

Re: flipper44 post# 676386

Tuesday, 03/05/2024 3:10:34 PM

Tuesday, March 05, 2024 3:10:34 PM

Post# of 708338
Now ask yourself, why did they say they will continue to monitor timelines.

05 March 2024 A meeting was held between NICE and the company in early-February regarding next steps for the appraisal of DCVax-L for treating glioblastoma, and more information WILL BE AVAILABLE in due course. NICE will continue liaising with the company and “monitoring timelines”. — NICE



Consider that there are two timelines.

We aim to publish final guidance (regarding appraisal timeline) for all new technologies within 90 days of receiving marketing authorisation (regarding MAA timeline) — NICE



Note: Within 90 days can mean well within, as DocLogic points out, NICE is trying to have appraisals happen nearly simultaneously after marketing approvals.

In other words, they are monitoring the appraisal timeline in juxtaposition to the approval timeline.

Got it?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News